Baader Bank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.04M Sell
75,561
-5,867
-7% -$484K 0.47% 48
2025
Q4
$6.94M Sell
81,428
-29,270
-26% -$2.4M 0.48% 47
2025
Q3
$8.6M Sell
110,698
-10,633
-9% -$831K 0.56% 35
2025
Q2
$9.46M Sell
121,331
-700
-0.6% -$52.2K 0.68% 31
2025
Q1
$8.83M Buy
122,031
+770
+0.6% +$55.1K 0.66% 33
2024
Q4
$8.98M Buy
121,261
+210
+0.2% +$14.7K 0.59% 36
2024
Q3
$7.99M Buy
121,051
+1,844
+2% +$134K 0.47% 70
2024
Q2
$11M Sell
119,207
-24,858
-17% -$2.2M 0.7% 24
2024
Q1
$13.8M Sell
144,065
-16,486
-10% -$1.38M 0.98% 20
2023
Q4
$12.2M Buy
160,551
+19,455
+14% +$1.35M 0.89% 31
2023
Q3
$9.77M Buy
141,096
+3,334
+2% +$268K 0.66% 50
2023
Q2
$13M Buy
137,762
+8,011
+6% +$696K 0.66% 50
2023
Q1
$10.7M Sell
129,751
-2,876
-2% -$226K 0.55% 58
2022
Q4
$9.9M Buy
132,627
+37,849
+40% +$2.92M 0.48% 79
2022
Q3
$7.83M Buy
94,778
+78,728
+491% +$7.58M 0.5% 69
2022
Q2
$1.53M Sell
16,050
-7,237
-31% -$749K 0.12% 158
2022
Q1
$2.74M Buy
23,287
+400
+2% +$44.9K 0.22% 81
2021
Q4
$2.96M Buy
+22,887
New +$2.67M 0.23% 92

Other funds holding EW

Baader Bank Aktiengesellschaft's EW Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Edwards Lifesciences (EW) stake by 7.2% in Q1 2026, selling an estimated $484K and leaving 75,561 shares worth $6.04M. The position accounts for 0.47% of the portfolio, ranked #48.

Baader Bank Aktiengesellschaft first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.8M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 75,561 shares of Edwards Lifesciences worth $6.04M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 5,867 Edwards Lifesciences shares in Q1 2026, an estimated $484K.
  • Edwards Lifesciences made up 0.47% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #48 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • Baader Bank Aktiengesellschaft's Edwards Lifesciences position peaked at $13.8M in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.